Mellissa Albert, PharmD
Tuesday, October 17, 2023
Category: Antimicrobial Resistance Mechanisms, Antimicrobial Stewardship, Bacterial Infections, Hospital Infections, Microbiology, Pharmacotherapy

Melissa Albert, Infectious Diseases Pharmacy Resident, discusses the recent new literature regarding changes in the clinical breakpoints. Utilizing clinical cases, Dr. Albert demonstrates how to interpret antimicrobial susceptibility reports as well as how to design a patient-centered treatment regimen. Dr. Albert also discusses inducible AmpC-E resistance and how specific breakpoints have been changed for Aminoglycosides.

Stay in touch! Download our app in the iTunes store or the Google Marketplace.